Two novel NPM1 mutations in a therapy‐responder AML patient

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hematological Oncology

• Publication date

  2009-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hon.906PMID 19593743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of nucleophosmin leads to distortion of nucleolar and nuclear structures in HeLa cells

  2008cited by this paper
• Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.

  2007cited by this paper
• Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements

  2006cited by this paper
• Requirement of the Protein B23 for Nucleolar Disassembly Induced by the FRGY2a Family Proteins*

  2006cited by this paper
• Long-Term Evolution and Functional Diversification in the Members of the Nucleophosmin/Nucleoplasmin Family of Nuclear Chaperones

  2006cited by this paper
• Nucleophosmin and cancer

  2006cited by this paper
• ACUTE MYELOID LEUKEMIA CARRYING CYTOPLASMIC / MUTATED NUCLEOPHOSMIN ( NPMc + AML ) : BIOLOGICAL AND CLINICAL FEATURES

  2006influential reference
• Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23

  2006cited by this paper
• Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

  2006influential reference
• Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

  2005cited by this paper
• Temporal and spatial control of nucleophosmin by the Ran–Crm1 complex in centrosome duplication

  2005cited by this paper
• Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.

  2005cited by this paper
• Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

  2005cited by this paper
• A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy.

  2004cited by this paper
• Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.

  2004cited by this paper
• Adult acute myeloid leukaemia.

  2004cited by this paper
• Acute myeloid leukemia

  2004cited by this paper
• Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia.

  2003cited by this paper
• Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses

  2003cited by this paper
• Genetics of myeloid leukemias.

  2003influential reference
• Functional proteomic analysis of melanoma progression.

  2003cited by this paper
• Nucleophosmin regulates the stability and transcriptional activity of p53

  2002cited by this paper
• Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.

  2002cited by this paper
• Tryptophans 286 and 288 in the C-terminal Region of Protein B23.1 are Important for Its Nucleolar Localization

  2002cited by this paper
• The Dynamics of Postmitotic Reassembly of the Nucleolus

  2000cited by this paper
• Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.

  2000cited by this paper
• Acute myeloid leukemia.

  1999cited by this paper
• EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA

  1996cited by this paper
• Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).

  1992cited by this paper
• Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase.

  1990cited by this paper

• Analysis and Interpretation of Somatic NMD-Escaping Variants in Oncogenes and Dual-Function Genes across Adult and Pediatric Cancer Cohorts

  2025cites this paper
• Identification of a novel NPM1 mutation in acute myeloid leukemia

  2023cites this paper
• High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.

  2017cites this paper
• ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML

  2017cites this paper
• Establishment of a quenching probe method for detection of NPM1 mutations in acute myeloid leukemia cells.

  2016cites this paper
• Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors

  2015cites this paper
• Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology

  2014cites this paper
• BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients

  2013cites this paper